Fatty acids modulate the expression levels of key proteins for cholesterol absorption in Caco-2 monolayer

Lipids Health Dis. 2018 Feb 20;17(1):32. doi: 10.1186/s12944-018-0675-y.

Abstract

Background: Fatty acids have been shown to modulate intestinal cholesterol absorption in cells and animals, a process that is mediated by several transporter proteins. Of these proteins, Niemann-Pick C1-Like 1 (NPC1L1) is a major contributor to this process. The current study investigates the unknown mechanism by which fatty acids modulate cholesterol absorption.

Methods: We evaluated the effects of six fatty acids palmitic acid (PAM), oleic acid (OLA), linoleic acid (LNA), arachidonic acid (ARA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on cholesterol uptake and transport in human enterocytes Caco-2 cells, and on the mRNA expression levels of NPC1L1, others proteins (ABCG5, ABCG8, ABCA1, ACAT2, MTP, Caveolin 1, Annexin-2) involved in cholesterol absorption, and SREBP-1 and SREBP-2 that are responsible for lipid metabolism.

Results: The polyunsaturated fatty acids (PUFAs), especially for EPA and DHA, dose-dependently inhibited cholesterol uptake and transport in Caco-2 monolayer, while saturated fatty acids (SFAs) and monounsaturated fatty acids (MUFAs) had no inhibitory effects. EPA and DHA inhibited cholesterol absorption in Caco-2 monolayer might be caused by down-regulating NPC1L1 mRNA and protein levels, which were associated with inhibition of SREBP-1/- 2 mRNA expression levels.

Conclusion: Results from this study indicate that functional food containing high PUFAs may have potential therapeutic benefit to reduce cholesterol absorption. Further studies on this topic may provide approaches to control lipid metabolism and to promote health.

Keywords: Caco-2 monolayer transport; Fatty acids; Intestinal cholesterol absorption; NPC1L1.

MeSH terms

  • ATP Binding Cassette Transporter 1 / genetics
  • ATP Binding Cassette Transporter 1 / metabolism
  • ATP Binding Cassette Transporter, Subfamily G, Member 5 / genetics
  • ATP Binding Cassette Transporter, Subfamily G, Member 5 / metabolism
  • ATP Binding Cassette Transporter, Subfamily G, Member 8 / genetics
  • ATP Binding Cassette Transporter, Subfamily G, Member 8 / metabolism
  • Annexin A2 / genetics
  • Annexin A2 / metabolism
  • Biological Transport / drug effects
  • Caco-2 Cells
  • Caveolin 1 / genetics
  • Caveolin 1 / metabolism
  • Cholesterol / metabolism*
  • Cholesterol / pharmacokinetics
  • Fatty Acids / pharmacokinetics
  • Fatty Acids / pharmacology*
  • Gene Expression Regulation / drug effects
  • Humans
  • Intestinal Absorption / drug effects
  • Lipoproteins / genetics
  • Lipoproteins / metabolism
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism
  • Membrane Transport Proteins
  • Oxidation-Reduction
  • Proteins / genetics
  • Proteins / metabolism*
  • Sterol O-Acyltransferase / genetics
  • Sterol O-Acyltransferase / metabolism
  • Sterol O-Acyltransferase 2
  • Sterol Regulatory Element Binding Protein 1 / genetics
  • Sterol Regulatory Element Binding Protein 1 / metabolism
  • Sterol Regulatory Element Binding Protein 2 / genetics
  • Sterol Regulatory Element Binding Protein 2 / metabolism

Substances

  • ABCA1 protein, human
  • ABCG5 protein, human
  • ABCG8 protein, human
  • ANXA2 protein, human
  • ATP Binding Cassette Transporter 1
  • ATP Binding Cassette Transporter, Subfamily G, Member 5
  • ATP Binding Cassette Transporter, Subfamily G, Member 8
  • Annexin A2
  • Caveolin 1
  • Fatty Acids
  • Lipoproteins
  • Membrane Proteins
  • Membrane Transport Proteins
  • NPC1L1 protein, human
  • Proteins
  • SREBF1 protein, human
  • SREBF2 protein, human
  • Sterol Regulatory Element Binding Protein 1
  • Sterol Regulatory Element Binding Protein 2
  • Cholesterol
  • Sterol O-Acyltransferase